Evidence-based guideline update: Plasmapheresis in neurologic disorders
- 25 October 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 77 (17), 1649-1652
- https://doi.org/10.1212/wnl.0b013e318230b33f
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Evidence-based guideline update: Plasmapheresis in neurologic disordersNeurology, 2011
- AAN guidelinesNeurology, 2010
- Prognosis of polyneuropathy due to IgM monoclonal gammopathyNeurology, 2010
- Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for ApheresisJournal of Clinical Apheresis, 2010
- Levels of evidenceNeurology, 2009
- Invited Article: Practice parameters and technology assessmentsNeurology, 2008
- Grading quality of evidence and strength of recommendationsBMJ, 2004
- Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trialsBMJ, 2003
- Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Plasma Exchange in Polyneuropathy Associated with Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 1991